Article
Identification of SCAF1 as a key factor affecting VEGF in LIHC and its potential target for therapy hypothesized based on network pharmacology and transcriptomics
2024-03-26
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction:</bold> Liver hepatocellular carcinoma (LIHC) is a highly vascularized entity closely associated with immune functions, characterized by high incidence, elusive early detection, high malignancy, and poor prognosis. SCAF1 participates in the immune regulation mechanisms of various cancers (gliomas, breast cancer, etc.) and is involved in regulating the level of gene tr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 615a1e15-8664-5d18-aae7-fbfc0b68feea
- DOI
- 10.21203/rs.3.rs-4117141/v1
